PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study

被引：29

作者：

Verstovsek, Srdan ^{[1
]}

Hasserjian, Robert P. ^{[2
]}

Pozdnyakova, Olga ^{[3
]}

Veletic, Ivo ^{[4
]}

Mesa, Ruben A. ^{[5
]}

Foltz, Lynda ^{[6
]}

Mascarenhas, John ^{[7
]}

Ritchie, Ellen K. ^{[8
]}

Palmer, Jeanne ^{[9
]}

Silver, Richard T. ^{[8
]}

Kremyanskaya, Marina ^{[10
]}

van den Blink, Bernt ^{[11
]}

Gupta, Renu ^{[11
]}

Manshouri, Taghi ^{[4
]}

Yin, C. Cameron ^{[12
]}

Estrov, Zeev E. ^{[1
]}

Gotlib, Jason R. ^{[13
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA

[6] Univ British Columbia, St Pauls Hosp, Vancouver, BC, Canada

[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[8] Weill Cornell Med, New York, NY USA

[9] Mayo Clin, Div Hematol & Med Oncol, Dept Med, Phoenix, AZ USA

[10] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[11] Promedior Inc, Lexington, MA USA

[12] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[13] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-115362

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

686

引用

页数：3